FindTrial
Sign In

Study on CAPG inhibiting ferroptosis to induce M1 macrophage polarization and counteract the progression of biliary atresia

Study on CAPG inhibiting ferroptosis to induce M1 macrophage polarization and counteract the progression of biliary atresia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125304
Enrollment
Unknown
Registered
2026-05-25
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary atresia

Interventions

Biliary atresia:NA

Sponsors

Fujian Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Meets the diagnostic criteria for biliary atresia.

Exclusion criteria

Exclusion criteria: Combined other genetic metabolic diseases and diseases with hepatobiliary structural abnormalities.

Design outcomes

Primary

MeasureTime frame
M1 polarization marker;—

Countries

China

Contacts

Public ContactLin Yijun

Fujian Children's Hospital

58646812@qq.com+86 159 8023 2660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026